首页 | 本学科首页   官方微博 | 高级检索  
     


Arterial access site and outcomes in patients undergoing percutaneous coronary intervention with and without vorapaxar
Authors:Jean‐Pierre Déry MD  MHS  Kenneth W. Mahaffey MD  Pierluigi Tricoci MD  PhD  Harvey D. White DSC  Mohua Podder PhD  Cynthia M. Westerhout PhD  David J. Moliterno MD  Robert A. Harrington MD  Edmond Chen MD  John Strony MD  Frans Van de Werf MD  Khaled M. Ziada MD  Claes Held MD  PhD  Philip E. Aylward MD  Paul W. Armstrong MD  Sunil V. Rao MD
Affiliation:1. Department of Cardiology and Cardiovascular Surgery, Institut Universitaire De Cardiologie Et De Pneumologie De Québec, Laval University, Quebec City, Canada;2. Department of Medicine, Department of Medicine, Stanford University, Stanford, California;3. Department of Medicine, Duke Clinical Research Institute, Durham, North Carolina;4. Department of Cardiology, Green Lane Cardiovascular Service, Auckland, New Zealand;5. Department of Economics, Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada;6. Department of Internal Medicine, Gill Heart Institute and Division of Cardiovascular Medicine, University of Kentucky, Lexington, Kentucky;7. Bayer HealthCare Pharmaceuticals, Department of Internal Medicine, Bayer HealthCare Pharmaceuticals, Whippany, New Jersey;8. Merck, New Jersey;9. Department of Cardiovascular Sciences, University Hospitals Leuven, Belgium;10. Department of Medical Sciences, Uppsala Clinical Research Center, Uppsala University, Sweden;11. Division of Medicine, SAHMRI, Flinders University and Medical Center, Adelaide, Australia
Abstract:
Keywords:hemorrhage  thrombin  inhibitors  myocardial infarction  coronary disease  angioplasty
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号